The nitric oxide system in glucocorticoid-induced hypertension

Journal of Hypertension

Volumn 20, Issue 6, 2002, Pages 1035-1043

  Whitworth, Judith A ^a   Schyvens, Christopher G ^a   Zhang, Yi ^a   Andrews, Miles C ^a   Mangos, George J ^a   Kelly, John J ^a  

^a Biology and Environment   (Australia)

Author keywords

Adrenocorticotrophic hormone; Animal; Cortisol; Glucocorticoid induced hypertension; Human; Hypertension; Nitric oxide

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

BIOAVAILABILITY; BLOOD PRESSURE MEASUREMENT; ENZYME ACTIVITY; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA VOLUME; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SODIUM RETENTION; WATER RETENTION; ANIMAL; CHEMICALLY INDUCED DISORDER; METABOLISM;

ANIMALS; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; NITRIC OXIDE;

EID: 0036591573     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200206000-00003     Document Type: Review

References (99)

1. Adrenocortical steroid hypertension: A historical perspective
2. + retention in man is not mediated by the mineralocorticoid receptor
3. Dose response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans
4. Mechanism of glucocorticoid-induced hypertension
5. Adrenocorticotrophin-induced hypertension: Effects of mineralocorticoid and glucocorticoid receptor antagonism
6. The hypertensive effect of synthetic glucocorticoids in man: Role of sodium and volume
7. Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions
8. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans
9. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits
10. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug
11. Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression
12. GTP cyclohydrolase I is coinduced in hepatocytes stimulated to produce nitric oxide
13. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase, which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
14. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells
15. Inhibition of interleukin-1 -alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1 -alpha-induced hypotension by N-omega-amino-L-arginine
16. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions
17. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans
18. Role of L-arginine-nitric oxide pathway in hypertension
19. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells
20. Endothelial cells have a particulate enzyme system responsible for EDRF formation: Measurement by vascular relaxation
21. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
22. The preferred source of arginine for high-output nitric oxide synthesis in blood vessels
23. Caveolar localization of arginine regeneration enzymes, argininoscuccinate synthase, and lyase, with endothelial nitric oxide synthase
24. GTP cyclohydrolase I inhibition by the prototypic inhibitor 2,4-diamino-6-hydroxypyrimidine
25. Nitric oxide production depends on preceding tetrahydrobiopterin synthesis by endothelial cells: Selective suppression of induced nitric oxide production by sepiapterin reductase inhibitors
26. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin
27. Enzymatic function of nitric oxide synthases
28. Tetrahydrobiopterin synthesis: An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle
29. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells
30. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: New perspectives on endothelium-derived relaxing factor
31. Tetrahydrobiopterin as another EDRF in man
32. Modulation of inducible nitric oxide synthase mRNA stability by tetrahydrobiopterin in vascular smooth muscle cells
33. Superoxide generation from endothelial nitric-oxide synthase
34. Tetrahydrobiopterin and endothelial nitric oxide synthase activity
35. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries
36. Nitric oxide regulation of tissue free radical injury
37. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling
38. Cell signalling by nitric oxide
39. Lack of tyrosine nitration by peroxynitrite generated at physiological pH
40. Synergistic antihypertensive effects of nifedipine on endothelium: Concurrent release of NO and scavenging of superoxide
41. L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells
42. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
43. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats
44. Relative deficiency of nitric oxide-dependent vasodilation in salt-Hypertensive Dahl rats: The possible role of superoxide anions
45. Does superoxide underlie the pathogenesis of hypertension?
46. How does ascorbic acid prevent endothelial dysfunction?
47. Vitamin E, membrane fluidity, and blood pressure in hypertensive and normotensive rats
48. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide
49. Nitric oxide-dependent induction of glutathione synthesis through increased expression of gamma-glutamylcysteine synthetase
50. Role of glutathione in stabilization of nitric oxide during hypertension developed by inhibition of nitric oxide synthase in the rat
51. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin
52. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: A role for superoxide
53. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
54. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport
55. Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages
56. Glucocorticoid regulation of nitric oxide and tetrahydrobiopterin in a rat model of endotoxic shock
57. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension
58. Dexamethasone worsens nitric oxide inhibition-induced hypertension and renal dysfunction
59. Potentiation of atrial natriuretic peptide-stimulated cyclic guanosine monophosphate formation by glucocorticoids in cultured rat renal cells
60. Dexamethasone sensitizes soluble guanylate cyclase in the rat renal glomeruli
61. Cortisol inhibits cholinergic vasodilatation in the human forearm
62. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats
63. Expression of xanthine oxidoreductase in mouse mammary epithelium during pregnancy and lactation: Regulation of gene expression by glucocorticoids and prolactin
64. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases
65. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells
66. Dexamethasone protection of rat intestinal epithelial cells against oxidant injury is mediated by induction of heat shock protein 72
67. Dexamethasone attenuates NF-kappa-B DNA binding activity without inducing I-kappa-B levels in rat brain in vivo
68. Dexamethasone-enhanced sensitivity of mouse hippocampal HT22 cells for oxidative stress is associated with the suppression of nuclear factor-kappa B
69. Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of rats treated with dexamethasone
70. Glucocorticoids may alter antioxidant enzyme capacity in the brain: Baseline studies
71. Excess of glucocorticoids impairs whole-body antioxidant status in young rats. Relation to the effect of dexamethasone in soleus muscle and spleen
72. Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis
73. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress
74. Changes in levels of catalase and glutathione in erythrocytes of patients with stable asthma, treated with beclomethasone dipropionate
75. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries
76. Surgical stress increases renal glutathione content via increased glucocorticoid, and resistance to subsequent oxidative injury in the rat: Significant link between endocrine response and cell defense system under the stress
77. Pretreatment with methylprednisolone protects the isolated rat heart against ischaemic and oxidative damage
78. Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats
79. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells
80. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat
81. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats
82. L-arginine prevents corticotropin-induced increases in blood pressure in the rat
83. Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine
84. Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat
85. L-arginine partially reverses established adrenocotrophin-induced hypertension and nitric oxide deficiency in the rat
86. Nitric oxide synthase activity in adrenocortiotrophin induced hypertension in the rat
87. Glomerular hypertension and hyperfiltration in adrenocorticotrophin-induced hypertension in rats: The role of nitric oxide
88. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotrophin-induced and corticosterone-induced hypertension
89. Chronic low-dose infusions of dexamethasone in rats: Effects on blood pressure, body weight and plasma arterial natriuretic peptide
90. Dexamethasone-induced hypertension in the rat: Effects of L-arginine
91. Effects of diet and measurement of nitric oxide metabolites
92. Nitric oxide system and cortisol-induced hypertension in humans
93. Role of nitric oxide resistance in erythropoeitin induced hypertension in rats with chronic renal failure
94. Role of erythropoietin in cortisol-induced hypertension
95. Erythropoietin receptor mRNA expression in human endothelial cells
96. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA
97. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits
98. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels
99. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol treated humans